Volcano
Corporation Schedules Events for
2008 TCT Transcatheter Cardiovascular
Therapeutics Meeting
|
 |
September 20, 2008 -- Volcano
Corporation (Nasdaq: VOLC), a leading manufacturer of intravascular
ultrasound (IVUS) and functional measurement (FM) technology, has
scheduled several events to be held during the 2008 TCT meeting
in Washington DC, being held October 12-17, 2008 at the Washington
Convention Center.
A special evening symposium, titled "The
Future of Intravascular Imaging: How IVUS, FFR, VH IVUS, CTO Imaging
and
OCT can improve everyday outcomes" will be held on
Tuesday, October 14, at the Renaissance Washington, DC, Hotel,
Renaissance Ballroom.
Registration and a reception will start at 7:00pm, and at 8:00pm
presentations by a number of prominent physicians will begin. To
register for the evening symposium, email TCT@Laser-Registration.com.
The scheduled talks are:
8:00pm The data supports more
IVUS with DES
Augusto D. Pichard
Washington Hospital Center
Washington, DC USA
8:15pm Fast, simple, integrated IVUS. No more excuses
Matthew J. Price
Scripps Clinic
La Jolla, CA USA
8:25pm Fast, simple, integrated FFR. No more excuses
Morton J. Kern
University of California Irvine
Orange, CA USA
8:40pm VH IVUS and where it fits.
Steven P. Marso
St. Luke's Hospital
Kansas City, MO USA
8:55pm The potential of OCT
Giulio Guagliumi
Ospedali Riuniti Di Bergamo
Bergamo, Italy
9:10pm The practicality of OCT
Alexandre Abizaid
Instituto Dante Pazzanese de Cardiologia
Sao Paulo, Brazil
9:20pm CTO Imaging to give everyone access
David O. Williams
Rhode Island Hospital
Providence, RI USA
9:35pm Tying it all together with integration
Gary S. Mintz
Cardiovascular Research Foundation
New York, NY USA
9:45pm Panel Discussion
Panel
10:00pm Adjourn
Volcano Corporation will also be hosting an investor
and analyst event on Tuesday, October 14, from 10:30-11:30am (ET)
at
the Grand Hyatt at Washington Center, 1000 H St., N.W.,
Conference Theatre. The keynote
speaker will be Dr. Gus Pichard, Professor of Cardiology Medicine
and Director of Cardiac Cath Labs at Washington Hospital Center.
Dr. Pichard will discuss trends in the use of IVUS with drug-eluting
stents, including the recently-introduced second generation devices.
In addition, Scott Huennekens, president and chief executive officer,
will provide a brief update on the company. A Q&A session will follow
the formal presentations. For more information, please contact
Cindy Birse at cbirse@volcanocorp.com or (916) 281-2854.
Additionally Volcano will be exhibiting its
latest technologies throughout the conference in the Exhibit Area
on Level 2, Booth #1006.
About Volcano Corporation
Volcano Corporation offers a broad suite of devices designed to facilitate
endovascular procedures, enhance the diagnosis of vascular and structural
heart
disease and guide optimal therapies. The company's intravascular
ultrasound (IVUS) product line includes ultrasound consoles that
can be integrated directly into virtually any modern cath lab. Volcano
IVUS offers unique features, including both single-use phased array
and rotational IVUS imaging catheters, and advanced functionality
options, such as VH® IVUS tissue characterization and ChromaFlo®.
Volcano also provides functional measurement (FM) consoles and single-use
pressure and flow guide wires and is developing a line of ultra-high
resolution Optical Coherence Tomography (OCT) and Forward Looking
IVUS systems and catheters. Currently, more than 3,500 Volcano IVUS
and FM systems are installed worldwide, with approximately half of
its revenues coming from outside the United States. For more information,
visit the company's website at http://www.volcanocorp.com.
About the TCT
This year's Transcatheter Cardiovascular
Therapeutics meeting marks a milestone: the 20th annual TCT.
Created and managed by the Cardiovascular Research
Foundation, based in New York,
the TCT meeting has evolved over the past two decades into
the premier interventional cardiology meeting, attended by
10,000
cardiologists
and related professionals worldwide. Attendees
will hear late-breaking clinical trial results, see live case
demonstrations
of innovative
procedures beamed via satellite from cath labs around the the
world, and will also get to visit and see the latest
technologies in the Exhibition
Hall, which occupies an entire floor of the Washington Convention
Center. As of the 2009 annual meeting of the American College
of Cardiology, the i2 Summit -- the ACC's special interventional
section -- will be managed by the Cardiovascular Research Foundation.
A complete program and other information about this year's meeting
can be viewed on the TCT website at http://www.tctconference.com.
Reported by Burt Cohen, September 20, 2008
|
